Listen and learn as Dr. Arnold and Dr. Strittmatter share their views about the current state of development in Alzheimer’s therapeutics; updates on what we know about the contributions from inflammation, vascular injury, and fundamental cell biology processes such as metabolic stress, protein misfolding, and synaptic plasticity; progress in biomarkers and their role in drug discovery; and ongoing clinical trials that portend a future built on a deepening knowledge about the disease.
February 2, 2022
4 pm Eastern (1 pm Pacific)
Steven E. Arnold, MD, Harvard Medical School
Stephen M. Strittmatter, MD, PhD, Yale School of Medicine
Moderator: Lena Chow, Bob’s Last Marathon Foundation